HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen - Wikidata - awgldk - TriplyDB

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

http://www.wikidata.org/entity/Q28390427

about

Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?

P2860

Q26995220-3BF5C9A9-376A-4BCF-A390-D9D8AE5E318F

P2860

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

http://www.wikidata.org/entity/Q28390427

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@ast

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@en

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@nl

type

label

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@ast

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@en

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@nl

prefLabel

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@ast

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@en

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@nl

P1433

Q28390427-4F3A913B-5C84-43D5-82D5-7BC2303748D3

P1476

Q28390427-D62978E5-DED9-4328-938A-756BA125D476

P2093

Q28390427-0DA493A8-A4C1-4DD5-968F-BCC453F6A97A

Q28390427-37E02162-F14C-4B50-9A3C-606709C50DA7

Q28390427-751266D5-3A0A-4346-91DB-91204CC6C437

Q28390427-EA0E1385-0334-4C03-BFDD-CC42D4836BE7

P2860

Q28390427-10937FC9-F211-4416-B0A8-8010662B5673

Q28390427-11D9CF27-A0FF-45F7-A17B-E23BA3E296E3

Q28390427-14420422-533E-417B-859F-33D2514E259C

Q28390427-15DB7062-0499-4A71-9A4B-B92CD26CB695

Q28390427-1E2DEC05-95F2-485C-8B7B-49CFEE2FBC6B

Q28390427-217BBE26-1547-4F25-89BD-19B99A3C2356

Q28390427-2B03A8C8-44DE-4627-9BC1-B7BE60E9258E

Q28390427-373B3F7D-0731-4ACB-92B9-DC1DFFD4D328

Q28390427-3C00AF0E-D0A1-46ED-87AD-2B3BAEC86C8A

Q28390427-437C8983-431A-485B-84AE-EFB4618F8314

P304

Q28390427-BD3CA498-D22F-4F9A-879E-BBE0D4644D35

P31

Q28390427-844E5FC4-DB89-4F0B-B73E-C9420232C136

P356

Q28390427-87461CB8-3061-42B1-B371-4850B5A5D0E7

P407

Q28390427-CE569334-DCCE-43B1-8D08-71C80DF57990

P433

Q28390427-F8CFAB91-E471-4D95-A7B5-DAF55564072E

P478

Q28390427-6105C4E0-191F-4ACA-8922-C30B53D1906F

P577

Q28390427-EC9F1D45-A7C8-44A9-93AD-1D2B27BEBA46

P5875

Q28390427-C682FE61-AED2-4CE7-AC8D-19C2AE2F95A5

P698

Q28390427-54170BAD-2D19-49BD-B099-856D1836AB0C

P932

Q28390427-7B976325-EBEC-4912-8BC3-A76B8FF0D2FF

P356

P1433

P1476

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

@en

P2093

Bart G Jones

http://www.w3.org/2001/XMLSchema#string

Julia L Hurwitz

http://www.w3.org/2001/XMLSchema#string

Robert Sealy

http://www.w3.org/2001/XMLSchema#string

Sherri L Surman

http://www.w3.org/2001/XMLSchema#string

P2860

Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides

Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1.

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.

Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

Application of the polyvalent approach to HIV-1 vaccine development.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

P304

268-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.5.4.7706

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26745665

http://www.w3.org/2001/XMLSchema#string

P698

19684481

http://www.w3.org/2001/XMLSchema#string

P932

2729359

http://www.w3.org/2001/XMLSchema#string